Three-Dimensional In Vitro Cell Culture Models in Drug Discovery
A special issue of Future Pharmacology (ISSN 2673-9879).
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 19236
Special Issue Editors
Interests: natural products; chemoprevention; cell culture systems; 3D culture; oncogenetic; cancer biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: cell culture systems; antimutagenesis; genotoxicity; oncogenetic; cancer biomarkers; epigenetic
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue provides a platform to publish original articles that will stimulate the continuing efforts to find cancer models that more faithfully mimic a tumor's microenvironment and will make cancer drug discovery more successful.
Based on experience in the fields above, we invite investigators to submit an original research paper as well as review articles for publication in this Special Issue. We are particularly interested in articles employing 3D cell cultures, as well as those comparing results between 2D and 3D models. Studies concerning spheroids obtained through ex vivo propagation of tumors from individual patients (tumor organoids) are particularly welcome.
Topics include but are not limited to: Nutraceuticals and Phytochemicals as anticancer drugs; Novel synthetic molecules with anticancer properties; Bioactive compounds targeting cell survival and proliferation; Association of chemotherapy drugs and bioactive compounds.
All submissions will be peer-reviewed, following the same evaluation criteria as individual Future Pharmacology submissions.
Prof. Dr. Juliana Mara Serpeloni
Prof. Dr. Colus Ilce Mara
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- spheroids
- 3D culture
- in vitro system
- phytochemicals
- organoids
- anticancer drugs
- chemotherapeutic drugs
- MCTS
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.